Stablix

Developer of a drug discovery platform that focuses on targeted protein stabilization

placeNew York City, New York, United States calendar_todayFounded 2021 groups25 employees language stablix.com

Innovation

4 patent families — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 19 times.

YearFilings
20221
20232
20243
20253

Investor mix

4 investors on record; lead investors include Versant Ventures.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%
Coming soon